NEURO FRANCE IMPLANTS : revenue, balance sheet and financial ratios

NEURO FRANCE IMPLANTS is a French company founded 28 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in LA VILLE-AUX-CLERCS (41160), this company of category PME shows in 2020 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NEURO FRANCE IMPLANTS (SIREN 417631959)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C 1 314 908 € 1 613 237 € 1 338 075 € 1 087 798 € 1 501 719 €
Net income -370 650 € 55 231 € 560 834 € 277 343 € -74 986 € 147 452 € -152 687 € -736 567 € -247 368 €
EBITDA N/C N/C N/C N/C 217 282 € 187 683 € 26 910 € -485 792 € -137 080 €
Net margin N/C N/C N/C N/C -5.7% 9.1% -11.4% -67.7% -16.5%

Revenue and income statement

In 2024, NEURO FRANCE IMPLANTS records a net loss of 371 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-370 650 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 75%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

75.032%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

31.997%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

8.9%

Solvency indicators evolution
NEURO FRANCE IMPLANTS

Sector positioning

Debt ratio
75.03 2024
2022
2023
2024
Q1: 1.92
Med: 18.86
Q3: 55.42
Average

In 2024, the debt ratio of NEURO FRANCE IMPLANTS (75.03) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
32.0% 2024
2022
2023
2024
Q1: 24.8%
Med: 50.27%
Q3: 69.09%
Average -13 pts over 3 years

In 2024, the financial autonomy of NEURO FRANCE IMPLANTS (32.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 214.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

214.572

Liquidity indicators evolution
NEURO FRANCE IMPLANTS

Sector positioning

Liquidity ratio
214.57 2024
2022
2023
2024
Q1: 159.64
Med: 253.69
Q3: 429.69
Average -26 pts over 3 years

In 2024, the liquidity ratio of NEURO FRANCE IMPLANTS (214.57) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
NEURO FRANCE IMPLANTS

Positioning of NEURO FRANCE IMPLANTS in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare NEURO FRANCE IMPLANTS with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Frequently asked questions about NEURO FRANCE IMPLANTS

What is the revenue of NEURO FRANCE IMPLANTS ?

The revenue of NEURO FRANCE IMPLANTS in 2020 is 1.3 M€.

Is NEURO FRANCE IMPLANTS profitable?

NEURO FRANCE IMPLANTS recorded a net loss in 2024.

Where is the headquarters of NEURO FRANCE IMPLANTS ?

The headquarters of NEURO FRANCE IMPLANTS is located in LA VILLE-AUX-CLERCS (41160), in the department Loir-et-Cher.

Where to find the tax return of NEURO FRANCE IMPLANTS ?

The tax return of NEURO FRANCE IMPLANTS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NEURO FRANCE IMPLANTS operate?

NEURO FRANCE IMPLANTS operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.